Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB

Abstract excerpt

// Yulia N. Demchenko 1 , Leslie A. Brents 1 , Zhihong Li 2 , Leif P. Bergsagel 3 , Lawrence R. McGee 2 , and Michael W. Kuehl 1 1 Genetics Branch, National Cancer Institute, Bethesda, MD, USA 2 Amgen, Inc. South San Francisco CA, USA 3 Comprehensive Cancer Center, Mayo Clinic Arizona, Scottsdale Correspondence: Michael Kuehl, email: // Keywords : NFkB-inducing kinase, NIK inhibitors, NFkB, IKKbeta inhibitors,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cytokine Signaling Pathways and Interactions
• Share to Multiple Myeloma Research and Treatments
• Share to NF-κB Signaling Pathways